Acneiform eruption caused by levonorgestrel-intrauterine system: a case report

Acneiform eruptions occur from a wide variety of diseases, including infections, hyperandrogenism and drug reactions. The levonorgestrel-intrauterine system [LNG-IUS] provides highly effective contraception by releasing levonorgestrel into the uterine cavity. We present a woman with acneiform eruption after insertion of the LNG-IUS for contraceptive purposes which resolved shortly after its removal. In reproductive age women with acneic eruption with unknown ordinary cause, LNG-IUS should be ascertained as a cause of acne

Glucose tolerance in pregnant women with vaginal candidiasis

Background: The use of traditional historic risk factors to identify gestational diabetes mellitus [GDM] will miss half of women with gestational diabetes mellitus. Our aim was to evaluate whether impaired glucose tolerance is a risk factor for vaginal candidiasis in pregnant women

Patients and Methods: In a cross-sectional study, we compared the prevalence of impaired glucose tolerance in 64 pregnant women with vaginal candidiasis [positive microscopy] and 59 Candida-negative control subjects. Subjects underwent standardized 75-gram oral glucose tolerance testing between the 24th and 28th weeks of their pregnancies. Patients were included only if they had no known diabetes mellitus or historic risk factors for gestational diabetes mellitus, and had not been receiving antibiotic or steroid therapy. We compared glucose levels at fasting, 30 minutes, 60 minutes and 120 minutes, and perinatal and neonatal outcomes in the two groups

Results: There were no statistical differences between cases and controls in demographic characteristics. Glucose concentrations were higher in pregnant women with vaginal candidiasis than in control subjects at fasting [89 vs. 84 mg/dL, P=0.021], 30 minutes [139 vs. 126 mg/dL, P=0.050], and 60 minutes [124 vs. 106 mg/dL, P= 0.018] after intake of 75 gram of glucose. The two groups did not differ in glucose level at 120 minutes after glucose administration. Gestational diabetes prevalence was 3.1% and 3.4% in the study and control group, respectively [P=0.274]

Conclusion: The tolerance to glucose in pregnant women with vaginal candidiasis seems discretely impaired